Lucira Health: Shares surge 30% on Nasdaq debut

Lucira Health

05/02/2021 17:04

** Shares of biotech  LHDX.O  jump 30% in their debut on
Nasdaq
    ** Stock opens at $22.10 per share, up from IPO price of $17
per share
    ** On Thursday, co sold 9 mln shares to raise ~$153 mln in
its upsized IPO  urn:newsml:reuters.com:*:nBw6BKtc6a
    ** Co had earlier aimed to sell ~7.8 mln shares at a range
between $15 and $17 apiece (https://bit.ly/3pNqDcd)
    ** LHDX said it focuses on the development of disease test
kits; its COVID-19 test kit is designed to provide a result
within 30 minutes from sample collection
    ** BofA Securities, William Blair and LifeSci Capital are
the underwriters for the offering

 (Reporting by Niket Nishant in Bengaluru)
 ((Niket.Nishant@thomsonreuters.com))